Press Release

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Periodic Fever Syndrome Market to Grow at a Steady Pace During 2021-2026, Aided by the Growing Research and Development Activities

According to a new report by EMR titled, ‘Global Periodic Fever Syndrome Market Report and Forecast 2021-2026’, the global market for periodic fever syndrome is expected to grow at a steady pace between 2021 and 2026.

There is a significant unmet need for patients who suffer from severe, debilitating diseases like periodic fever syndromes, particularly children. There are no specific confirmatory laboratory or genetic tests to detect these conditions, however, the increase in the number of clinical trials taking place across the world are expected to significantly aid the industry growth. In developed regions like the United States and the European Union, the growing investments by the governments and stringent health regulations are driving the growth of the regional markets.

Earlier, there was no approved medicine for the treatment of TNF Receptor-Associated Periodic Syndrome (TRAPS), Hyperimmunoglobulinemia D Syndrome (HIDS)/ Mevalonate Kinase Deficiency (MKD), and Familial Mediterranean Fever (FMF). In September 2016, Novartis AG (NYSE: NVS), a key player in the industry, announced that the company has received three new approvals from the US Food and Drug Administration (FDA) for the expanded use of Ilaris® (canakinumab) to treat these rare and distinct types of periodic fever syndromes. Ilaris has already got approval for the treatment of the periodic fever syndrome CAPS in over 70 countries, like in the EU, Switzerland, Canada, and Japan. Such developments are expected to positively aid the industry growth over the forecast period.

Market Breakup by Treatment, Indication, Route of Administration, Distribution Channel, End Use, and Region:

  • The market can be divided based on treatment into oral anti-inflammatory drugs, non-steroidal anti-inflammatory drugs, anti-TNF therapy, and statins, among others. 
  • On the basis of indication, the industry can be categorised into hyperimmunoglobulinemia D syndrome, familial mediterranean fever, TNF receptor-associated periodic syndrome, and cryopyrin-associated periodic syndrome, among others. 
  • By route of administration, the industry can be segmented into oral and injections, among others. 
  • The market is divided based on distribution channel into hospital pharmacy, retail pharmacy, and online, among others.
  • On the basis of end use sector, the industry can be segmented into hospitals and specialty centres, among others. 
  • Region-wise, the global market for periodic fever syndrome can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

  • The industry is being driven by the rapid technological advancements and the increasing investments in R&D activities. 
  • The favourable government initiatives are further propelling the market growth. 
  • The growing investments to develop the healthcare infrastructure across the globe are also accelerating the growth rate of the industry.

Key Offerings of the Report:

  • The EMR report gives an overview of the global market for periodic fever syndrome for the periods (2016-2020) and (2021-2026). 
  • The report also offers historical (2016-2020) and forecast (2021-2026) market information for the treatments, indications, routes of administration, distribution channels, end uses, and regional markets of periodic fever syndrome.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global periodic fever syndrome market are Swedish Orphan Biovitrum AB, Novartis AG, and Texas Allergy Group, PLLC, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players. 

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.